Change for Clariant's board of directors

首页> 外文期刊>Textile month international >Change for Clariant's board of directors

【24h】

Change for Clariant's board of directors

机译：科莱恩董事会的变动

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Dr Rudolf Wehrli has been promoted to chairman of Clariant's board of directors following the decision of Dr Jurg Witmer to stand down from the role. This changeover took place at Clariant's 17th Annual General Meeting (AGM) on March 27. According to the company, Dr Witmer will now focus more on his longstanding directorship mandates as well as taking on new challenges in Asia in the future.

机译：在Jurg Witmer博士决定退任该职位后，Rudolf Wehrli博士已升任科莱恩董事会主席。这一转变是在3月27日举行的科莱恩第17届年度股东大会（AGM）上进行的。据该公司称，维特默博士现在将更加专注于其长期担任董事职务，以及未来在亚洲面临的新挑战。

著录项

来源
《Textile month international》 |2012年第2期|p.42|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Clariant's change of board of directors [J] . ATA Journal . 2012,第2期

机译：科莱恩董事会变更
2. Changes in Clariant's Board of Directors [J] . Paintindia Group Paintindia . 2008,第3期

机译：科莱恩董事会的变动
3. Deepak Parikh, Clariant to join American Chemistry Council Board of Directors [J] . Paintindia Group Paintindia . 2018,第6期

机译：深度帕克，科莱恩加入美国化学委员会董事会
4. The panel model empirical analysis of the effect of member age of board of directors and independence on corporate performance: Examples from Tokyo main board listed companies in Japanese manufacturing industry [C] . Li Bin, Zhang Jun, Zheng Chenggong 2011 2nd International Conference on Artificial Intelligence, Management Science and Electronic Commerce . 2011

机译：董事会成员年龄和独立性对公司绩效影响的面板模型实证分析：以日本制造业的东京主板上市公司为例
5. Have boards of directors changed? A study of the impact of Sarbanes-Oxley legislation on corporate governance. [D] . DeClouette, Anshila Horton. 2009

机译：董事会有变吗？萨班斯-奥克斯利法案对公司治理的影响研究。
6. The Strategic Change Initiatives Portfolio: 2006 Report of the Board of Directors to the AACP House of Delegates [O] . Lucinda L. Maine 2006

机译：战略变革计划投资组合：董事会向AACP众议院提交的2006年报告
7. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)44The ACC/AHA Task Force on Practice Guidelines makes every effort to avoid any actual or potential conflicts of interest that might arise as a result of an outside relationship or personal interest of a member of the writing panel. Specifically, all members of the writing panel are asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur.55This document was approved by the American College of Cardiology Foundation Board of Trustees in July, 2003, the American Heart Association Science Advisory and Coordinating Committee in July, 2003, and the American Society of Nuclear Cardiology Board of Directors in July, 2003.66When citing this document, the American College of Cardiology Foundation, the American Heart Association, and the American Society of Nuclear Cardiology request that the following citation format be used: Klocke FJ, Baird MG, Bateman TM, Berman DS, Carabello BA, Cerqueira MD, DeMaria AN, Kennedy JW, Lorell BH, Messer JV, O’Gara PT, Russell RO Jr, St. John Sutton MG, Udelson JE, Verani MS, Williams KA. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318–33.77(J Am Coll Cardiol 2003;42:1318–33)88©2003 by the American College of Cardiology Foundation and the American Heart Association, Inc. [O] . Klocke Francis J, Baird Michael G, Lorell Beverly H, 2003

机译：ACC / AHA / ASNC心脏放射性核素成像临床使用指南-执行摘要美国心脏病学会/美国心脏协会实践指南工作组的报告（ACC / AHA / ASNC委员会，对1995年临床使用指南进行修订ACC / AHA实践指导小组）竭尽全力避免由于写作小组成员的外部关系或个人利益而引起的任何实际或潜在的利益冲突。具体来说，要求写作小组的所有成员提供所有可能被视为实际或潜在利益冲突的关系的披露声明。这些声明由上级工作组审查，在第一次会议上向书面小组的所有成员口头报告，并在发生变化时进行更新。55本文件于2003年7月获得美国心脏病学会基金会董事会的批准。 2003年7月，美国心脏协会科学咨询与协调委员会，2003年7月，美国核心脏病学会理事会。66引用该文件时，美国心脏病学会基金会，美国心脏协会和美国核学会心脏病学要求使用以下引用格式：Klocke FJ，Baird MG，Bateman TM，Berman DS，Carabello BA，Cerqueira MD，DeMaria AN，Kennedy JW，Lorell BH，Messer JV，O'Gara PT，Russell RO Jr，St John Sutton MG，Udelson JE，Verani MS，Williams KA。 ACC / AHA / ASNC心脏放射性核素成像临床使用指南-执行摘要：美国心脏病学会/美国心脏协会实践小组工作指南（ACC / AHA / ASNC委员会，修订1995年临床指南）的报告使用放射性核素成像）。 J Am Coll Cardiol 2003; 42：1318–33.77（J Am Coll Cardiol 2003; 42：1318–33）88©2003美国心脏病学会基金会和美国心脏协会版权所有。
8. Boards, Commissions, and Committees: Board of Directors, Army and Air Force Exchange Service (AAFES). [R] . 1996

机译：委员会，委员会和委员会：董事会，陆军和空军交换服务（aaFEs）。

Change for Clariant's board of directors

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅